CareFusion Corp to be Included in S&P...() ventilation and respiratory products C...),Health

Date:8/25/2009

) ventilation and respiratory products, ChloraPrep(R) for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller(R) surgical instruments and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations. The company has been authorized to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN." More information may be found at carefusion.com.

Cautions concerning forward-looking statements

This news release contains forward-looking statements addressing the planned spinoff of the clinical and medical products businesses of Cardinal Health as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10, as amended, and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those filings and reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.

'/>"/>

SOURCE CareFusion Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine news :

1. CareFusion Issues Update Regarding Previously Disclosed June 12, 2009 Recall of the Alaris(R) System
2. CareFusion Form 10 Registration Statement Declared Effective
3. CareFusion Expands Pyxis(R) Perioperative Solutions Offering
4. CareFusion Prices $1.4 Billion of Senior Notes
5. Cardinal Health Board of Directors Approves CareFusion Spinoff
6. CareFusion to Resume Shipping Alaris(R) Infusion Products
7. CareFusion Corporation Launches International Jazz Festival Series
8. CareFusion Files Amended Form 10 Registration Statement With SEC
9. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
10. CareFusion Names Robert Friel to Board of Directors
11. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree